U S PHYSICAL THERAPY INC /NV - Common Stock (USPH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
USPH on NYSE
Shares outstanding
15,234,314
Price per share
$78.09
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
16,024,919
Total reported value
$1,361,025,879
% of total 13F portfolios
0%
Share change
+431,715
Value change
+$38,772,446
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
242
Price from insider filings
$71.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% $169,079,035 2,162,136 BlackRock, Inc. 30 Jun 2025
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 9.8% +61% $117,955,466 +$43,734,185 1,486,334 +59% Kayne Anderson Rudnick Investment Management, LLC 30 Jun 2025
MORGAN STANLEY 5.9% $60,006,488 889,644 Morgan Stanley 31 Dec 2024
Copeland Capital Management, LLC 5.5% -5.2% $71,696,186 +$14,202,451 843,981 +25% Copeland Capital Management, LLC 30 Sep 2025
As of 30 Sep 2025, U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) has 242 institutional shareholders filing 13F forms. They hold 16,024,919 shares. .

Top 25 institutional shareholders own 84% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 2,177,623 -2.3% 0% $184,989,033
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 8.9% 1,353,357 -9% 0.28% $114,967,760
MORGAN STANLEY 7.4% 1,132,817 +8.1% 0.01% $96,232,971
VANGUARD GROUP INC 7% 1,069,624 -0.43% 0% $90,864,560
Copeland Capital Management, LLC 5.5% 843,981 -5% 1.5% $71,696,293
STATE STREET CORP 4.3% 654,535 +0.63% 0% $55,602,748
SOUTHERNSUN ASSET MANAGEMENT, LLC 3.3% 505,222 -0.52% 5.6% $42,918,609
Boston Trust Walden Corp 3.2% 490,068 -1.6% 0.31% $41,631,276
BAHL & GAYNOR INC 3.1% 474,688 +48% 0.2% $40,324,746
DIMENSIONAL FUND ADVISORS LP 3.1% 474,244 +6.2% 0.01% $40,285,082
GEODE CAPITAL MANAGEMENT, LLC 2.3% 354,140 +0.34% 0% $30,088,609
GW&K Investment Management, LLC 2.3% 350,881 -16% 0.26% $29,807,000
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.3% 345,859 0.08% $29,380,722
Rockefeller Capital Management L.P. 2.2% 340,812 +0.67% 0.06% $28,952,038
ENVESTNET ASSET MANAGEMENT INC 2.2% 337,208 -2.6% 0.01% $28,645,831
BANK OF AMERICA CORP /DE/ 2.1% 317,200 +77% 0% $26,946,137
AMERICAN CENTURY COMPANIES INC 1.7% 258,265 0.01% $21,939,820
SCHRODER INVESTMENT MANAGEMENT GROUP 1.6% 249,635 -35% 0.02% $20,844,523
NORTHERN TRUST CORP 1.5% 229,743 -2.3% 0% $19,516,667
WELLS FARGO & COMPANY/MN 1.1% 164,389 -6.4% 0% $13,964,886
FMR LLC 1% 153,674 -7.3% 0% $13,054,604
CRAWFORD INVESTMENT COUNSEL INC 0.96% 146,752 +7.4% 0.21% $12,466,545
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.94% 142,681 +2.6% 0% $12,120,751
Bank of New York Mellon Corp 0.82% 125,214 -4.8% 0% $10,636,912
Point72 Asset Management, L.P. 0.81% 123,026 -55% 0.02% $10,451,056

Institutional Holders of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 21,856 $1,719,883 -$296,327 7,809.31% 6
2025 Q3 16,024,919 $1,361,025,879 +$38,772,446 8,495% 242
2025 Q2 15,603,014 $1,220,352,681 +$28,791,118 7,820% 237
2025 Q1 15,293,795 $1,107,121,992 -$19,791,948 7,236% 252
2024 Q4 15,565,122 $1,381,034,235 +$12,224,751 8,871% 254
2024 Q3 15,433,476 $1,305,757,796 +$18,383,601 8,463% 254
2024 Q2 15,172,253 $1,402,254,310 -$59,249,178 9,242% 240
2024 Q1 15,618,754 $1,762,911,037 +$17,934,190 11,287% 234
2023 Q4 15,447,185 $1,438,773,106 +$3,869,053 9,314% 211
2023 Q3 15,398,086 $1,412,523,676 +$4,037,253 9,173% 216
2023 Q2 15,234,561 $1,848,475,452 +$186,901,768 12,139% 210
2023 Q1 13,701,294 $1,341,722,062 +$28,779,416 9,791% 195
2022 Q4 13,436,114 $1,088,773,930 +$71,739,919 8,103% 194
2022 Q3 13,124,739 $998,171,735 -$72,742,621 7,602% 189
2022 Q2 13,042,508 $1,423,973,455 +$34,859,639 10,919.99% 203
2022 Q1 12,815,293 $1,273,306,835 +$8,895,292 9,945.14% 203
2021 Q4 12,738,854 $1,217,788,483 -$20,797,020 9,554.96% 205
2021 Q3 12,685,017 $1,403,954,486 -$3,110,434 11,060% 203
2021 Q2 12,698,610 $1,471,332,128 +$13,558,739 11,586.96% 213
2021 Q1 12,599,376 $1,311,957,414 -$14,349,614 10,410.29% 206
2020 Q4 12,764,246 $1,535,159,218 -$22,751,760 12,025% 197
2020 Q3 12,985,104 $1,128,051,401 -$46,160,851 8,688% 176
2020 Q2 13,515,168 $1,094,651,503 +$19,402,988 8,101.93% 180
2020 Q1 13,351,705 $921,296,121 +$19,464,416 6,899.81% 190
2019 Q4 12,924,295 $1,477,714,610 -$44,728,400 11,434.82% 207
2019 Q3 13,250,312 $1,729,728,320 -$2,304,276 13,055% 214
2019 Q2 13,271,359 $1,626,744,820 +$8,075,962 12,256.97% 208
2019 Q1 13,292,015 $1,396,358,290 +$22,783,322 10,503% 213
2018 Q4 13,072,681 $1,337,403,503 +$40,794,523 10,235% 191
2018 Q3 12,630,800 $1,497,836,136 +$22,980,270 11,859.98% 190
2018 Q2 12,478,565 $1,198,021,484 +$26,927,841 9,600% 181
2018 Q1 12,209,224 $992,784,036 +$23,386,753 8,130.02% 169
2017 Q4 11,942,869 $862,309,117 +$7,256,344 7,219.92% 162
2017 Q3 11,860,056 $728,879,542 -$8,509,114 6,145% 164
2017 Q2 11,945,577 $721,586,733 -$6,817,725 6,039.93% 170
2017 Q1 12,086,488 $789,275,470 +$109,121,993 6,530% 175
2016 Q4 12,099,976 $848,180,561 +$31,709,886 7,019.94% 171
2016 Q3 11,705,168 $733,868,495 -$2,163,359 6,269.97% 171
2016 Q2 11,727,836 $706,127,990 -$623,739 6,020.94% 164
2016 Q1 11,796,875 $586,662,968 -$27,589,089 4,973.13% 148
2015 Q4 12,301,670 $659,824,574 +$34,790,533 5,367.92% 140
2015 Q3 11,749,307 $527,975,618 +$6,403,280 4,488.92% 131
2015 Q2 11,589,911 $632,548,209 +$15,217,377 5,475.87% 127
2015 Q1 11,344,025 $538,532,637 +$6,545,844 4,750.03% 128
2014 Q4 11,244,101 $471,661,219 +$1,815,064 4,195.94% 124
2014 Q3 11,221,457 $397,119,203 +$5,112,011 3,538.93% 111
2014 Q2 11,082,636 $379,137,986 +$217,061 3,419% 106
2014 Q1 11,074,925 $382,192,809 +$4,067,884 3,457% 105